Position in ZTS
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$328,975
-$262,311 QoQ
Shares Held
4,578
-8.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#894
of 1,408 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Valeo Financial Advisors, LLC holds $1,567,354 across 8 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (21.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
4,578 | $328,975 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
1,679 | $282,978 | |
| 3 | HIMS |
Hims & Hers Health, Inc.
|
6,484 | $224,800 | |
| 4 | HLN |
Haleon plc
|
19,789 | $184,631 | |
| 5 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
10,045 | $180,408 | |
| 6 | VTRS |
Viatris Inc
|
10,836 | $172,075 | |
| 7 | TAK |
Takeda Pharmaceutical Co Ltd
|
10,141 | $162,560 | |
| 8 | CRON |
Cronos Group Inc.
|
11,125 | $30,927 |
All Filings in ZTS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $328,975 | 4,578 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $591,286 | 5,002 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $540,648 | 4,297 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $800,516 | 5,471 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $834,644 | 5,352 | Shares | Sole | 2025-09-12 | |
| 2025-03-31 | $1,167,533 | 7,091 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $1,224,744 | 7,517 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $1,568,510 | 8,028 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $1,375,958 | 7,937 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $1,284,134 | 7,589 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $1,357,313 | 6,877 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $713,839 | 4,103 | Shares | Sole | 2023-10-20 | |
| 2023-06-30 | $725,865 | 4,215 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $661,099 | 3,972 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $486,106 | 3,317 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $513,676 | 3,464 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $535,437 | 3,115 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $743,044 | 3,940 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $636,430 | 2,608 | Shares | Sole | 2022-01-07 | |
| 2021-09-30 | $496,998 | 2,560 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $419,123 | 2,249 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $359,526 | 2,283 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $346,226 | 2,092 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $347,773 | 2,103 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $328,484 | 2,397 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $262,801 | 2,233 | Shares | Sole | 2020-04-13 | |
| No filing history on record for this holder in this stock. | ||||||